Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Johnson

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Nature Reviews. Disease Primers|January 19, 2023
Author Correction: Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Plos One|November 18, 2016
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck CancerNoah D Peyser, Kelsey Pendleton, William E Gooding, et al.
Nature Reviews. Disease Primers|November 27, 2020
Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Molecular Cancer Therapeutics|July 30, 2009
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell deathChangyou Li, Yan Zang, Malabika Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cellsMiriam Lango, Abbey L Wentzel, John I Song, et al.
Molecular Medicine (Cambridge, Mass.)|January 8, 2014
Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effectsMalabika Sen, Kathleen Paul, Maria L Freilino, et al.
Head & Neck|August 4, 2021
PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistanceNeil E Bhola, Christian Njatcha, Lanlin Hu, et al.
Oncogene|June 9, 2004
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2Dong Xiao, Sunga Choi, Daniel E Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Human Papilloma Virus does not fully inactivate p53 cellular activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Oral Oncology|July 27, 2019
ATR inhibition sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> head and neck squamous cell carcinoma to cisplatinBrandon C Leonard, Eliot D Lee, Neil E Bhola, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Nature Reviews. Disease Primers|January 19, 2023
Author Correction: Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Plos One|November 18, 2016
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck CancerNoah D Peyser, Kelsey Pendleton, William E Gooding, et al.
Nature Reviews. Disease Primers|November 27, 2020
Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Molecular Cancer Therapeutics|July 30, 2009
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell deathChangyou Li, Yan Zang, Malabika Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cellsMiriam Lango, Abbey L Wentzel, John I Song, et al.
Molecular Medicine (Cambridge, Mass.)|January 8, 2014
Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effectsMalabika Sen, Kathleen Paul, Maria L Freilino, et al.
Head & Neck|August 4, 2021
PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistanceNeil E Bhola, Christian Njatcha, Lanlin Hu, et al.
Oncogene|June 9, 2004
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2Dong Xiao, Sunga Choi, Daniel E Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Human Papilloma Virus does not fully inactivate p53 cellular activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Oral Oncology|July 27, 2019
ATR inhibition sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> head and neck squamous cell carcinoma to cisplatinBrandon C Leonard, Eliot D Lee, Neil E Bhola, et al.
Pageof 11